Repositorio Dspace

Prognosis of Paradoxical Low-Flow Low-Gradient Aortic Stenosis: A Severe, Non-critical Form, With Surgical Treatment Benefits

Mostrar el registro sencillo del ítem

dc.contributor.author Galian-Gay, Laura
dc.contributor.author Escalona-Silva, Roxana-Andreina
dc.contributor.author Teixido-Tura, Gisela
dc.contributor.author Casas, Guillem
dc.contributor.author Ferrer-Sistach, Elena
dc.contributor.author Mitroi, Cristina
dc.contributor.author Mingo, Susana
dc.contributor.author Monivas, Vanessa
dc.contributor.author Saura, Daniel
dc.contributor.author Vidal, Bárbara
dc.contributor.author Trasca, Livia
dc.contributor.author Moral, Sergio
dc.contributor.author Calvo, Francisco
dc.contributor.author Castineira-Busto, María
dc.contributor.author Sánchez, Violeta
dc.contributor.author González, Ariana
dc.contributor.author Guzman, Gabriela
dc.contributor.author Noris-Mora, Marta
dc.contributor.author Arnau-Vives, Miguel-Ángel
dc.contributor.author Peteiro, Jesús
dc.contributor.author Bouzas, Alberto
dc.contributor.author Mas-Stachurska, Aleksandra
dc.contributor.author González-Alujas, Teresa
dc.contributor.author Gutiérrez, Laura
dc.contributor.author Fernández-Galera, Rubén
dc.contributor.author Valente, Filipa
dc.contributor.author Guala, Andrea
dc.contributor.author Ruiz-Muñoz, Aroa
dc.contributor.author Augusto-Sao-Avilés, César
dc.contributor.author Rodríguez-Palomares, José-F
dc.contributor.author Ferreira, Ignacio
dc.contributor.author Evangelista, Artur
dc.date.accessioned 2025-11-21T08:44:01Z
dc.date.available 2025-11-21T08:44:01Z
dc.date.issued 2022-04-01
dc.identifier.citation Galian-Gay L, Escalona Silva RA, Teixidó-Turà G, Casas G, Ferrer-Sistach E, Mitroi C, et al. Prognosis of Paradoxical Low-Flow Low-Gradient Aortic Stenosis: A Severe, Non-critical Form, With Surgical Treatment Benefits. Front Cardiovasc Med. 1 de abril de 2022;9:852954.
dc.identifier.issn 2297-055X
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/21923
dc.description.abstract OBJECTIVES: To determine the risk of mortality and need for aortic valve replacement (AVR) in patients with low-flow low-gradient (LFLG) aortic stenosis (AS). METHODS: A longitudinal multicentre study including consecutive patients with severe AS (aortic valve area [AVA] < 1.0 cm(2)) and normal left ventricular ejection fraction (LVEF). Patients were classified as: high-gradient (HG, mean gradient ? 40 mmHg), normal-flow low-gradient (NFLG, mean gradient < 40 mmHg, indexed systolic volume (SVi) > 35 ml/m(2)) and LFLG (mean gradient < 40 mmHg, SVi ? 35 ml/m(2)). RESULTS: Of 1,391 patients, 147 (10.5%) had LFLG, 752 (54.1%) HG, and 492 (35.4%) NFLG. Echocardiographic parameters of the LFLG group showed similar AVA to the HG group but with less severity in the dimensionless index, calcification, and hypertrophy. The HG group required AVR earlier than NFLG (p < 0.001) and LFLG (p < 0.001), with no differences between LFLG and NFLG groups (p = 0.358). Overall mortality was 27.7% (CI 95% 25.3-30.1) with no differences among groups (p = 0.319). The impact of AVR in terms of overall mortality reduction was observed the most in patients with HG (hazard ratio [HR]: 0.17; 95% CI: 0.12-0.23; p < 0.001), followed by patients with LFLG (HR: 0.25; 95% CI: 0.13-0.49; p < 0.001), and finally patients with NFLG (HR: 0.29; 95% CI: 0.20-0.44; p < 0.001), with a risk reduction of 84, 75, and 71%, respectively. CONCLUSIONS: Paradoxical LFLG AS affects 10.5% of severe AS, and has a lower need for AVR than the HG group and similar to the NFLG group, with no differences in mortality. AVR had a lower impact on LFLG AS compared with HG AS. Therefore, the findings of the present study showed LFLG AS to have an intermediate clinical risk profile between the HG and NFHG groups.
dc.language.iso eng
dc.publisher FRONTIERS MEDIA SA
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/es/  *
dc.title Prognosis of Paradoxical Low-Flow Low-Gradient Aortic Stenosis: A Severe, Non-critical Form, With Surgical Treatment Benefits
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 35433871
dc.relation.publisherversion https://www.frontiersin.org/articles/10.3389/fcvm.2022.852954/full
dc.identifier.doi 10.3389/fcvm.2022.852954
dc.journal.title Frontiers in Cardiovascular Medicine


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta